LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, announced eight new client partnerships, additional hires and the launch of an investor relations thought leadership series. This builds on the agency’s foundational accounts with winning public and private global health companies and industry organizations.
New clients represent both public and privately held pre-commercial and commercial companies in key areas of industry growth, including cell, stem and gene therapy, CNS, rare disease, oncology, cardiovascular and retinopathy, as well as life science service providers.
LHS also began working in partnership with LeadingBiotech, a KNECT365 Informa business. The two firms will work in partnership to communicate and co-promote an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue meetings.
LHS’s work highlights the strength of our people and our collaborations and the importance of LHS’s proprietary methodologies including the LHS Immersion® and Blueprint plan, which forms the basis of core strategic communications and marketing programming.
“It’s all about our people and our clients—we keep them close. In our eighteenth year as a firm, I could not be more excited about our industry and its role in advancing health innovation,” said Donna L. LaVoie, President and CEO. “Working with unique and innovative clients and helping them tell their stories with a purpose, while solving complex communications challenges builds value and makes it worthwhile.”
To support a growing client roster, LHS has added Emmie Twombly as a Media Relations Specialist, Jessica Morris and Hannah Mongeon, both Account Coordinators and Harriet Ullman as a Senior Consultant, Product Communications. Emmie brings to the team media and public relations experience in the healthcare and financial sectors, placing print, online and broadcast stories. In addition to her strong strategic communications and writing background, she brings a passion for empowering women and developing thought leadership pieces. Jessica Morris and Hannah Mongeon came to LHS as part of the Mass Life Science Center Internship Challenge and bring excellent support to our teams.
Harriet Ullman brings 25 plus years of business and communications experience in the pharmaceutical industry and business consulting and was previously Vice President in the Healthcare Practice at Ogilvy PR/Feinstein Kean Healthcare. She provides clients with integrated communications support – from product communications, advocacy relationship management and media relations to strategic corporate positioning, branding and issues management.
In addition to expanding its strategic communications team this month, LHS also debuted the LHS IRalert, a thought leadership series aimed at providing updates on key IR trends for life science companies. The first alert informs life science companies on what they need to know about MiFID II.
